James M Foran (James Foran)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Topics

Acute Myeloid Leukemia

Top Venues

Blood cancer journal

British journal of haematology

Cancer medicine

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Steven C Ames, Lori Lange, Gretchen E Ames, Michael G Heckman, Launia J White, Vivek Roy, James M Foran
A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients. Cancer medicine (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Steven C Ames, Lori Lange, Gretchen E Ames, Michael G Heckman, Launia J White, Vivek Roy, James M Foran
A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients. Cancer medicine 13 (3) (2024)
Steven C Ames, Lori Lange, Gretchen E Ames, Michael G Heckman, Launia J White, Vivek Roy, James M Foran
A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients. Cancer medicine 13 (3) (2024)
Steven C Ames, Lori Lange, Gretchen E Ames, Michael G Heckman, Launia J White, Vivek Roy, James M Foran
A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients. Cancer medicine 13 (3) (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Steven C Ames, Lori Lange, Gretchen E Ames, Michael G Heckman, Launia J White, Vivek Roy, James M Foran
A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients. Cancer medicine 13 (3) (2024)
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah K Choe, Mark R Litzow, Camille N Abboud, Nebu Koshy, Patrick Joseph Stiff, Benjamin K Tomlinson, Sunil Abhyankar, James M Foran, Parameswaran N Hari, George Chen, Zaid Al-Kadhimi, Partow Kebriaei, Mitchell Sabloff, Johnnie J Orozco, Katarzyna Jamieson, Margarida Silverman, Koen van Besien, Michael Schuster, Arjun Datt Law, Karilyn T M Larkin, Neeta Pandit-Taskar, Scott Douglas Rowley, Pashna Munshi, Rachel Cook, Moshe Y Levy, Hillard M Lazarus, Brenda M Sandmaier, John M Pagel, Vijay Reddy, James MacDougall, Kathleen McNamara, Jennifer Spross, Elaina Haeuber, Madhuri Vusirikala, Akash Nahar, Avinash Desai, Sergio A Giralt
Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naseema Gangat, Helen Ajufo, Maymona Abdelmagid, Omer Karrar, Kristen McCullough, Talha Badar, James M Foran, Jeanne Palmer, Hassan B Alkhateeb, Abhishek A Mangaonkar, Andrew T Kuykendall, Raajit K Rampal, Ayalew Tefferi
IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. British journal of haematology (2023)
Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref A Al-Kali, Abhishek A Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Vinod Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mirinal S Patnaik
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 13 (1) (2023)
Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun Vinod Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref A Al-Kali
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. British journal of haematology (2023)
Ayalew Tefferi, Farah Fleti, Onyee Chan, Najla H Al Ali, Aref A Al-Kali, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Mithun Vinod Shah, Devendra K Hiwase, Eric Padron, David A Sallman, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q). British journal of haematology (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Ahmad Nanaa, Rong He, James M Foran, Talha Badar, Naseema Gangat, Animesh D Pardanani, William J Hogan, Mark R Litzow, Mrinal Patnaik, Aref A Al-Kali, Hassan B Alkhateeb
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients. British journal of haematology (2023)
James M Foran, Zhuoxin Sun, Catherine E Lai, Hugo F Fernandez, Larry D Cripe, Rhett P Ketterling, Janis Racevskis, Selina M Luger, Elisabeth Paietta, Hillard M Lazarus, Yanming Zhang, John M Bennett, Ross L Levine, Jacob M Rowe, Mark R Litzow, Martin S Tallman
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis. Cancer (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Maymona G Abdelmagid, Aref A Al-Kali, Mark R Litzow, Kebede H Begna, William Joseph Hogan, Mirinal S Patnaik, Shahrukh K. Hashmi, Michelle A Elliott, Hassan B Alkhateeb, Omer S Karrar, Farah Fleti, Mohammed H Elnayir, Candido E Rivera, Hemant S Murthy, James M Foran, Mohamed A Kharfan-Dabaja, Talha Badar, David S Viswanatha, Kaaren K Reichard, Naseema Gangat, Ayalew Tefferi
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events. Blood cancer journal 13 (1) (2023)
Vu H Duong, Amy S Ruppert, Alice S Mims, Uma Borate, Eytan M Stein, Maria R Baer, Wendy Stock, Tibor Kovacsovics, William G Blum, Martha L Arellano, Gary J Schiller, Rebecca L Olin, James M Foran, Mark R Litzow, Tara L Lin, Prapti A Patel, Matthew C Foster, Robert L Redner, Zeina Al-Mansour, Christopher R Cogle, Ronan T Swords, Robert H Collins, Jo-Anne Vergilio, Nyla A Heerema, Leonard Rosenberg, Ashley O Yocum, Sonja Marcus, Timothy Chen, Franchesca Druggan, Mona Stefanos, Theophilus J Gana, Abigail B Shoben, Brian J Druker, Amy Burd, John C Byrd, Ross L Levine, Michael M Boyiadzis
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial. Cancer (2023)
Aref A Al-Kali, Ahmad Nanaa, David Viswanatha, Rong He, Phuong Nguyen, Dragan Jevremovic, James M Foran, Cecelia Arana Yi, Patricia T Greipp, Naseema Gangat, Mirinal S Patnaik, Ayalew Tefferi, Mark R Litzow, Abhishek A Mangaonkar, Mithun Vinod Shah, Talha Badar, Hassan B Alkhateeb
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome. Blood cancer journal 13 (1) (2023)
Naseema Gangat, Kristen McCullough, Aref A Al-Kali, Kebede H Begna, Mrinal M Patnaik, Mark R Litzow, William Hogan, Mithun Vinod Shah, Hassan Alkhateeb, Abhishek A Mangaonkar, James M Foran, Jeanne M Palmer, Animesh D Pardanani, Ayalew Tefferi
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real-world experience. British journal of haematology 198 (4) (2022)
Claire N Harrison, Jacqueline S Garcia, Tim C P Somervaille, James M Foran, Srdan Verstovsek, Catriona Jamieson, Ruben A Mesa, Ellen K Ritchie, Srinivas K Tantravahi, Pankit Vachhani, Casey L O'Connell, Rami S Komrokji, Jason Harb, Jessica E Hutti, Leanne Holes, Abdullah A Masud, Silpa Nuthalapati, Jalaja Potluri, Naveen Pemmaraju
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (15) (2022)
Anmol Baranwal, Ahmad Nanaa, David Viswanatha, Rong He, James M Foran, Talha Badar, William Joseph Hogan, Mark R Litzow, Mithun Vinod Shah, Mirinal S Patnaik, Aref Al-Kali, Hassan B Alkhateeb
Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia. Bone marrow transplantation 57 (11) (2022)
Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B Alkhateeb, Mark R Litzow, Patricia Greipp, Taimur Sher, Peter Leif Bergsagel, Rafael Fonseca, Vivek Roy, Angela Dispenzieri, Mohamed A Kharfan-Dabaja, Hemant S Murthy, Sikandar Ailawadhi, James M Foran
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma. Blood cancer journal 12 (6) (2022)
Maymona G Abdelmagid, Mark R Litzow, McCullough Kristen, Naseema Gangat, Animesh Pardanani, Hemant S Murthy, James M Foran, Rhett P Ketterling, David Viswanatha, Kebede H Begna, Ayalew Tefferi
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases. Blood cancer journal 12 (7) (2022)
Zaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, Mikolaj Wieczorek, Kevin C Miller, Hassan Alkhateeb, Lisa Z Sproat, Hemant S Murthy, William J Hogan, Mohamed A Kharfan-Dabaja, Jess F Peterson, Linda B Baughn, Nicole Hoppman, Mark R Litzow, Rhett P Ketterling, Patricia T Greipp, James M Foran
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia. British journal of haematology (2021)
Zaid H Abdel-Rahman, Michael G Heckman, Theodora Anagnostou, Launia J White, Sara M Kloft-Nelson, Ryan A Knudson, Hassan B Alkhateeb, Lisa Z Sproat, Nandita Khera, Hemant S Murthy, Ernesto Ayala, William Joseph Hogan, Vivek Roy, Jess F Peterson, Mohamed A Kharfan-Dabaja, Rhett P Ketterling, Mark R Litzow, Linda B Baughn, Mirinal S Patnaik, Patricia T Greipp, James M Foran
Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes. Blood cancer journal 11 (9) (2021)
David P Steensma, Martin Wermke, Virginia M Klimek, Peter L Greenberg, Patricia Font, Rami S Komrokji, Jay Yang, Andrew M Brunner, Hetty E Carraway, Lionel Ades, Aref A Al-Kali, Juan M Alonso-Dominguez, Ana Alfonso-Piérola, Catherine C Coombs, H Joachim Deeg, Ian W Flinn, James M Foran, Guillermo Garcia Manero, Michael B Maris, Malgorzata McMasters, Jean-Baptiste Micol, Jaime Perez De Oteyza, Felicitas Thol, Eunice S Wang, Justin M Watts, Justin Taylor, Richard Stone, Vikram Gourineni, Alyssa J Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. Leukemia 35 (12) (2021)
Maansi Joshi, Joselle Cook, McCullough Kristen, Ahmad Nanaa, Naseema Gangat, James M Foran, Hemant S Murthy, Mohamed A Kharfan-Dabaja, Lisa Sproat, Jeanne Palmer, Animesh Pardanani, Ayalew Tefferi, Kebede Begna, Michelle Elliot, Aref A Al-Kali, Mirinal S Patnaik, Mithun Vinod Shah, William Joseph Hogan, Mark R Litzow, Hassan B Alkhateeb
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation. Blood cancer journal 11 (3) (2021)
Erica D Warlick, Celalettin Ustun, Astrid Andreescu, Anthony F Bonagura, Andrew Brunner, Abhinav B Chandra, James M Foran, Mark B Juckett, Tamila L Kindwall-Keller, Virginia M Klimek, Daniel F Pease, David P Steensma, Bryce M Waldman, Mary M Horowitz, Linda J Burns, Nandita Khera
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation. Cancer 127 (23) (2021)
Naseema Gangat, Erika Morsia, James M Foran, Jeanne M Palmer, Michelle A Elliott, Ayalew Tefferi
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients. British journal of haematology 191 (5) (2020)
Gautam Borthakur, Yishai Ofran, Martin S Tallman, James M Foran, Geoffrey L Uy, John F DiPersio, Margaret M Showel, Avichai Shimoni, Arnon Nagler, Jacob M Rowe, Jessica K Altman, Michal Abraham, Amnon Peled, Stephen Shaw, Osnat Bohana-Kashtan, Ella Sorani, Yaron Pereg, Adam Foley-Comer, Galia Oberkovitz, Tzipi M Lustig, Irit Glicko-Kabir, Arnon Aharon, Abi Vainstein-Haras, Shaul E Kadosh, Emil Samara, Ahmed N Al-Rawi, Naveen Pemmaraju, Carlos Bueso-Ramos, Jorge E Cortes, Michael Andreeff
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study. Cancer 127 (8) (2020)
Manuel Beltran, Sharad Khurana, Yennifer Gil, Jason T Lewis, Rohit Kumar, James M Foran
Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review. Case reports in hematology 2020 (2020)
William A Hammond, Pooja Advani, Rhett P Ketterling, Daniel Van Dyke, James M Foran, Liuyan Jiang
Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia. Case reports in hematology 2018 (2018)
Abhisek Swaika, Ryan D Frank, Dongyun Yang, Laura E Finn, Liuyan Jiang, Pooja Advani, Asher A Chanan-Khan, Sikandar Ailawadhi, James M Foran
Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes. Cancer medicine 7 (2) (2017)